Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Protalix Biotherapeutics (PLX)

Protalix Biotherapeutics (PLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Protalix Biotherapeutics 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 ISR

P: 201-696-9345

Description:

Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.

Key Statistics

Overview:

Market Capitalization, $K 88,497
Shares Outstanding, K 45,383
Annual Sales, $ 62,900 K
Annual Net Income, $ -6,520 K
Last Quarter Sales, $ 11,320 K
Last Quarter Net Income, $ -5,480 K
60-Month Beta 2.73
% of Insider Shareholders 3.27%
% of Institutional Shareholders 19.37%
Float, K 43,899
% Float 96.73%

Growth:

1-Year Return -47.44%
3-Year Return -54.65%
5-Year Return -70.00%
5-Year Revenue Growth 1,342.66%
5-Year Earnings Growth 92.41%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/09/21
Earnings Per Share ttm -0.38
EPS Growth vs. Prev Qtr -566.67%
EPS Growth vs. Prev Year -240.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 12/20/19

PLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.49
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -17.37%
Profit Margin % -10.37
Net Margin % -267.37
Debt/Equity N/A
Price/Sales 1.34
Price/Cash Flow N/A
Price/Book 5.88
Book Value/Share 0.32
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar